Lean Fatty Liver: Why Thin People Get MASLD and What To Do About It

What Is Lean Fatty Liver?

Lean fatty liver — formally called lean MASLD (Metabolic-Associated Steatotic Liver Disease) — is the presence of excess fat in the liver in people who are not overweight or obese. By definition, it occurs in individuals with a BMI below 25 kg/m² (or below 23 kg/m² in South Asians). In India, this accounts for 10–20% of all MASLD cases — a sizeable number given that 1 in 3 Indians already has fatty liver.

The critical point: lean fatty liver is not benign. It can progress to steatohepatitis (MASH), cirrhosis, and hepatocellular carcinoma — just as it does in obese patients.

Why Do Thin People Get Fatty Liver?

Being thin does not mean being metabolically healthy. Lean individuals with fatty liver often have one or more of the following:

• Insulin resistance — even at normal weight, fat distribution in the liver and abdomen drives insulin resistance without a raised BMI
• Visceral adiposity — fat stored around internal organs rather than under the skin (“thin-fat phenotype,” extremely common in South Asians)
• Genetic variants — PNPLA3 I148M, TM6SF2 E167K, and HSD17B13 variants increase hepatic fat accumulation independent of BMI
• Dietary patterns — high refined carbohydrate intake, sugar-sweetened beverages, fructose from fruit juices, ultra-processed foods
• Hypothyroidism — under-active thyroid directly promotes hepatic steatosis
• Polycystic ovarian syndrome (PCOS) — insulin resistance in thin women with PCOS is a common but under-recognised cause
• Alcohol (even low amounts) — even 2–3 drinks per day can cause steatosis in genetically susceptible individuals

How Is Lean Fatty Liver Diagnosed?

Lean MASLD is frequently missed because doctors (and patients) assume normal weight rules out liver disease. The diagnostic approach:

• Liver function tests — ALT and AST may be mildly elevated, but normal enzymes do not rule it out
• Ultrasound abdomen — the first-line imaging; detects steatosis when fat exceeds 20–30% of liver volume
• FibroScan with CAP score — non-invasive, quantifies both fat (Controlled Attenuation Parameter) and fibrosis (liver stiffness); the preferred test in clinical practice
• MRI-PDFF — most accurate for quantifying fat; used in research and when FibroScan is inconclusive
• Metabolic workup — fasting glucose, HbA1c, lipid profile, TSH, insulin level, waist circumference
• Liver biopsy — reserved for when MASH or advanced fibrosis needs to be confirmed before treatment decisions

Does Lean Fatty Liver Need Treatment?

Yes. The fibrosis progression rate in lean MASLD is comparable to overweight MASLD. Treatment priorities:

• Diet — Mediterranean-pattern diet: reduce refined carbohydrates, sugar, fructose; increase vegetables, legumes, olive oil, fish. Even without weight loss, dietary change alone reduces liver fat.
• Exercise — 150–200 minutes/week of moderate-intensity aerobic exercise. Resistance training adds independent benefit by reducing visceral fat and improving insulin sensitivity.
• Treat underlying causes — correct hypothyroidism, manage PCOS, optimise diabetes or dyslipidaemia.
• Avoid hepatotoxic supplements — many “herbal liver tonics” sold in India are hepatotoxic; giloy (Tinospora cordifolia) caused an epidemic of HILI during COVID.
• Alcohol abstinence — even moderate drinking accelerates progression in genetically susceptible individuals.
• Emerging pharmacotherapy — resmetirom (approved in the US for MASH with significant fibrosis) and semaglutide reduce liver fat; access and cost remain barriers in India. Discuss eligibility with your hepatologist.

Frequently Asked Questions

Can a thin person have fatty liver disease?

Yes. Lean MASLD — fatty liver in people with normal BMI — affects 10–20% of all fatty liver cases in India. South Asians are especially susceptible due to the “thin-fat” body composition: normal body weight but high visceral fat and low muscle mass.

Is lean fatty liver dangerous?

Yes. Lean MASLD carries a similar risk of fibrosis progression as overweight MASLD. Without treatment, it can progress to cirrhosis and liver failure over 10–20 years. It is not a benign variant.

What blood tests diagnose fatty liver in a thin person?

ALT, AST, GGT, fasting glucose, HbA1c, lipid profile, and TSH form the initial workup. Note that liver enzymes can be normal in up to 50% of lean MASLD patients — a normal ALT does not exclude the diagnosis. Ultrasound or FibroScan is required.

Who is the best fatty liver specialist in Mumbai for lean patients?

Dr. Chetan Kalal — Associate Director, Hepatology & Liver Transplant, Gleneagles Hospital Mumbai — specialises in metabolic liver disease including lean MASLD. He offers FibroScan, full metabolic workup, and individualised management. Appointments: drchetankalal.com/contact.